Instead, the NHTSA is still fielding reports of steering inconsistencies from those who had the recall remedy performed.

More than 40,000 Mazda CX-90 SUVs are now being investigated after a recall, as owners are reporting issues with the steering to NHTSA.

Teleflex cut its full-year revenue outlook for 2025, citing softer-than-expected demand and order delays. The medical-technologies company on Thursday said it now expects to report revenue of $3.27 ...

Wondering if Teleflex is a beaten down opportunity or a value trap at today’s price? Let us walk through what the numbers are really saying about the stock. After sliding 3.8% over the last week, ...

Despite a 1.7M-vehicle recall, Honda’s sticky steering lawsuit will run deep into 2026 as owners claim the issue was known long before any fix was offered. Consolidated class action alleges Honda knew ...

Deren provided updated financial guidance for 2025, raising total constant currency growth expectations to 7.7%-8.7% from the previous 1%-2%, driven by the BIOTRONIK ...

Teleflex, a medical technology company, announced that it has finalized its acquisition of the vascular intervention business of Biotronik. In February, Teleflex entered into a definitive agreement ...

The National Highway Traffic Safety Administration has opened an investigation into a possible problem with a particular Jaguar Land Rover model. According to NHTSA, the investigation covers Range ...

There can be a number of reasons why your steering wheel may be shaking while you are driving at higher speeds. Nearly all of these (sometimes the problem is just poorly maintained roads in your area) ...

I took some time to speak with the chief engineer of the McLaren 620R and learn all about McLaren's philosophy on steering. We'll talk about the history of power steering, what McLaren believes to be ...

Teleflex (TFX) came out with quarterly earnings of $2.91 per share, beating the Zacks Consensus Estimate of $2.88 per share. This compares to earnings of $3.21 per share a year ago. These figures are ...

Teleflex's (NYSE: TFX) fourth-quarter 2024 earnings conference call, held on February 27, 2025, revealed significant strategic shifts for the medical device company. In a transformative announcement, ...